Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: A systematic review of randomized clinical trials

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Bogaty, Peter ^a   Filion, Kristian B ^b   Brophy, James M ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; CLOPIDOGREL; RETEPLASE; STREPTOKINASE; TENECTEPLASE; FIBRINOLYTIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CORONARY STENT; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; NONSURGICAL INVASIVE THERAPY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; CASE REPORT; COMPARATIVE STUDY; DISEASE MANAGEMENT; DRUG EFFECT; FIBRINOLYSIS; HEART ATRIUM; HEART INFARCTION; MALE; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW;

AGED; DISEASE MANAGEMENT; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEART ATRIA; HUMANS; MALE; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79959194585     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-34     Document Type: Article

References (46)

1. Topol EJ, O'Neill WW, Langburd AB, Walton JA, Bourdillon PD, Bates ER, Grines CL, Schork AM, Kline E, Pitt B. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation 1987, 75:420-428. 10.1161/01.CIR.75.2.420, 2948735.
2. Belenkie I, Knudtson ML, Roth DL, Hansen JL, Traboulsi M, Hall CA, Manyari D, Filipchuck NG, Schnurr LP, Rosenal TW, et al. Relation between flow grade after thrombolytic therapy and the effect of angioplasty on left ventricular function: a prospective randomized trial. Am Heart J 1991, 121:407-416. 10.1016/0002-8703(91)90706-N, 1990744.
3. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group. JAMA 1988, 260:2849-2858.
4. Forrester JS, Liebson PR, Parrillo JE, Klein LW. Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy?. Prog Cardiovasc Dis 2002, 45:49-66. 10.1053/pcad.2002.123464, 12138414.
5. Verheugt FW. Routine angioplasty after fibrinolysis-how early should "early" be?. N Engl J Med 2009, 360:2779-2781. 10.1056/NEJMe0902460, 19553652.
6. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110:e82-292.
7. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329. 10.1161/CIRCULATIONAHA.107.188209, 18071078.
8. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 120:2271-2306. 10.1161/CIRCULATIONAHA.109.192663, 19923169.
9. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
10. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W264.
11. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, Davis J, Pitt M, Banning A, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005, 353:2758-2768. 10.1056/NEJMoa050849, 16382062.
12. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, Wright RA, Smith RH, et al. One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial. Heart 2005, 91:1330-1337. 10.1136/hrt.2004.047753, 1769146, 16162629.
13. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Phillips CO, Kashani A, You JJ, Tu JV, Ko DT. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007, 49:422-430. 10.1016/j.jacc.2006.09.033, 17258087.
14. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006, 367:579-588. 10.1016/S0140-6736(06)68148-8, 16488801.
15. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008, 358:2205-2217. 10.1056/NEJMoa0706816, 18499565.
16. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000, 21:823-831. 10.1053/euhj.1999.1993, 10781354.
17. Bednar F, Widimsky P, Krupicka J, Groch L, Aschermann M, Zelizko M. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol 2003, 19:1133-1137.
18. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Bohm M. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003, 42:634-641. 10.1016/S0735-1097(03)00763-0, 12932593.
19. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, Alonso-Briales J, Lopez-Mesa J, Fernandez-Vazquez F, Calvo I, Martinez-Elbal L, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004, 364:1045-1053. 10.1016/S0140-6736(04)17059-1, 15380963.
20. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, Maloney J, McKibbin T, Quinn B, Beanlands RS, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 2005, 46:417-424. 10.1016/j.jacc.2005.04.042, 16053952.
21. Schroder K, Wegscheider K, Zeymer U, Tebbe U, Schroder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001, 358:1479-1486. 10.1016/S0140-6736(01)06577-1, 11705559.
22. So DY, Ha AC, Davies RF, Froeschl M, Wells GA, Le May MR. ST segment resolution in patients with tenecteplase-facilitated percutaneous coronary intervention versus tenecteplase alone: Insights from the Combined Angioplasty and Pharmacological Intervention versus Thrombolysis ALone in Acute Myocardial Infarction (CAPITAL AMI) trial. Can J Cardiol 26:e7-12.
23. Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, Hartmann A, Pfeiffer D, Kneissl GD, Schneider D, et al. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005, 26:1956-1963. 10.1093/eurheartj/ehi432, 16061501.
24. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001, 357:1905-1914.
25. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006, 27:1530-1538. 10.1093/eurheartj/ehl088, 16757491.
26. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, Dimopoulos K, Manari A, Gaspardone A, Ochala A, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008, 371:559-568. 10.1016/S0140-6736(08)60268-8, 18280326.
27. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360:2705-2718. 10.1056/NEJMoa0808276, 19553646.
28. Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances Results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2010, 55:102-110. 10.1016/j.jacc.2009.08.007, 19747792.
29. Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, Changezi HU, Antman EM, Braunwald E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol 2001, 88:831-836. 10.1016/S0002-9149(01)01887-2, 11676942.
30. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol 2003, 42:7-16. 10.1016/S0735-1097(03)00506-0, 12849652.
31. Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008, 118:268-276. 10.1161/CIRCULATIONAHA.107.762765, 18591434.
32. Wijeysundera HC, You JJ, Nallamothu BK, Krumholz HM, Cantor WJ, Ko DT. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials. Am Heart J 2008, 156:564-572. 572 e561-562, 10.1016/j.ahj.2008.04.024, 18760142.
33. Borgia F, Goodman SG, Halvorsen S, Cantor WJ, Piscione F, Le May MR, Fernandez-Aviles F, Sanchez PL, Dimopoulos K, Scheller B, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J 2010, 31:2156-2169. 10.1093/eurheartj/ehq204, 20601393.
34. Desch S, Eitel I, Rahimi K, de Waha S, Schuler G, Thiele H. Timing of invasive treatment after fibrinolysis in ST elevation myocardial infarction-a meta-analysis of immediate or early routine versus deferred or ischemia-guided randomised controlled trials. Heart 2010, 96:1695-1702. 10.1136/hrt.2010.193862, 20736192.
35. Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2009, 54:477-486. 10.1016/j.jacc.2009.03.063, 19628125.
36. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994, 272:859-866. 10.1001/jama.272.11.859, 8078163.
37. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare Patients with acute myocardial infarction. Jama 2005, 293:1329-1337. 10.1001/jama.293.11.1329, 1459288, 15769966.
38. Kaul P, Chang WC, Lincoff AM, Aylward P, Betriu A, Bode C, Califf RM, Ohman EM, Guetta V, Steg PG, et al. Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial. Eur Heart J 2006, 27:1198-1206.
39. Pilote L, Beck CA, Eisenberg MJ, Humphries K, Joseph L, Penrod JR, Tu JV. Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases. Am Heart J 2008, 155:42-48. 10.1016/j.ahj.2007.09.016, 18082487.
40. Scott IA, Harden H, Coory M. What are appropriate rates of invasive procedures following acute myocardial infarction? A systematic review. Med J Aust 2001, 174:130-136.
41. Collet JP, Montalescot G, Le May M, Borentain M, Gershlick A. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol 2006, 48:1326-1335. 10.1016/j.jacc.2006.03.064, 17010790.
42. Stone GW. Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions. Circulation 2008, 118:552-566. 10.1161/CIRCULATIONAHA.107.739243, 18663103.
43. White HD. Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis. Circulation 2008, 118:219-222. 10.1161/CIRCULATIONAHA.108.790170, 18625904.
44. Verheugt FW. Lyse now, stent later: the grace of GRACIA. Lancet 2004, 364:1014-1015. 10.1016/S0140-6736(04)17072-4, 15380948.
45. Nainggolan L. Latest European and US STEMI guidelines compared and contrasted. The Heart org 2009, http://www.theheart.org/article/1019675.do
46. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009, 301:831-841. 10.1001/jama.2009.205, 19244190.